K Schmidt1, S Mwaigwisya1, L C Crossman2, M Doumith3, D Munroe4, C Pires5, A M Khan5, N Woodford3, N J Saunders5, J Wain1, J O'Grady6, D M Livermore1,3. 1. Norwich Medical School, University of East Anglia, Norwich, UK. 2. SequenceAnalysis.co.uk, Norwich Research Park, Norwich, UK. 3. AMRHAI Reference Unit, National Infection Service, Public Health England, London, UK. 4. Microbiology Department, Norfolk and Norwich University Hospital, Norwich, UK. 5. Brunel University London, Uxbridge, UK. 6. Norwich Medical School, University of East Anglia, Norwich, UK justin.ogrady@uea.ac.uk.
Abstract
OBJECTIVES: The introduction of metagenomic sequencing to diagnostic microbiology has been hampered by slowness, cost and complexity. We explored whether MinION nanopore sequencing could accelerate diagnosis and resistance profiling, using complicated urinary tract infections as an exemplar. METHODS: Bacterial DNA was enriched from clinical urines (n = 10) and from healthy urines 'spiked' with multiresistant Escherichia coli (n = 5), then sequenced by MinION. Sequences were analysed using external databases and bioinformatic pipelines or, ultimately, using integrated real-time analysis applications. Results were compared with Illumina data and resistance phenotypes. RESULTS: MinION correctly identified pathogens without culture and, among 55 acquired resistance genes detected in the cultivated bacteria by Illumina sequencing, 51 were found by MinION sequencing directly from the urines; with three of the four failures in an early run with low genome coverage. Resistance-conferring mutations and allelic variants were not reliably identified. CONCLUSIONS: MinION sequencing comprehensively identified pathogens and acquired resistance genes from urine in a timeframe similar to PCR (4 h from sample to result). Bioinformatic pipeline optimization is needed to better detect resistances conferred by point mutations. Metagenomic-sequencing-based diagnosis will enable clinicians to adjust antimicrobial therapy before the second dose of a typical (i.e. every 8 h) antibiotic.
OBJECTIVES: The introduction of metagenomic sequencing to diagnostic microbiology has been hampered by slowness, cost and complexity. We explored whether MinION nanopore sequencing could accelerate diagnosis and resistance profiling, using complicated urinary tract infections as an exemplar. METHODS: Bacterial DNA was enriched from clinical urines (n = 10) and from healthy urines 'spiked' with multiresistant Escherichia coli (n = 5), then sequenced by MinION. Sequences were analysed using external databases and bioinformatic pipelines or, ultimately, using integrated real-time analysis applications. Results were compared with Illumina data and resistance phenotypes. RESULTS: MinION correctly identified pathogens without culture and, among 55 acquired resistance genes detected in the cultivated bacteria by Illumina sequencing, 51 were found by MinION sequencing directly from the urines; with three of the four failures in an early run with low genome coverage. Resistance-conferring mutations and allelic variants were not reliably identified. CONCLUSIONS: MinION sequencing comprehensively identified pathogens and acquired resistance genes from urine in a timeframe similar to PCR (4 h from sample to result). Bioinformatic pipeline optimization is needed to better detect resistances conferred by point mutations. Metagenomic-sequencing-based diagnosis will enable clinicians to adjust antimicrobial therapy before the second dose of a typical (i.e. every 8 h) antibiotic.
Authors: Kathryn M Pendleton; John R Erb-Downward; Yuwei Bao; William R Branton; Nicole R Falkowski; Duane W Newton; Gary B Huffnagle; Robert P Dickson Journal: Am J Respir Crit Care Med Date: 2017-12-15 Impact factor: 21.405
Authors: Qun Yan; Yu Mi Wi; Matthew J Thoendel; Yash S Raval; Kerryl E Greenwood-Quaintance; Matthew P Abdel; Patricio R Jeraldo; Nicholas Chia; Robin Patel Journal: J Clin Microbiol Date: 2019-01-30 Impact factor: 5.948
Authors: Yong Wang; Kai Tian; Ruicheng Shi; Amy Gu; Michael Pennella; Lindsey Alberts; Kent S Gates; Guangfu Li; Hongxin Fan; Michael X Wang; Li-Qun Gu Journal: ACS Sens Date: 2017-07-05 Impact factor: 7.711
Authors: Scott Quainoo; Jordy P M Coolen; Sacha A F T van Hijum; Martijn A Huynen; Willem J G Melchers; Willem van Schaik; Heiman F L Wertheim Journal: Clin Microbiol Rev Date: 2017-10 Impact factor: 26.132